MEDICAL THREAD HAVING POLYGONAL CROSS-SECTIONED STOPPER ON ONE END, AND MANUFACTURING METHOD FOR SAME
20230190266 · 2023-06-22
Assignee
Inventors
Cpc classification
B29C51/08
PERFORMING OPERATIONS; TRANSPORTING
A61B17/0487
HUMAN NECESSITIES
C08L77/00
CHEMISTRY; METALLURGY
C08L67/04
CHEMISTRY; METALLURGY
C08L77/00
CHEMISTRY; METALLURGY
C08L27/18
CHEMISTRY; METALLURGY
A61B17/0401
HUMAN NECESSITIES
C08L67/04
CHEMISTRY; METALLURGY
International classification
A61B17/06
HUMAN NECESSITIES
Abstract
The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive force and penetration resistance, and to a manufacturing method for same.
Claims
1. A medical thread comprising: a body; and a stopper connected to one end of the body, wherein the end of the body connected to the stopper has a circular cross section, wherein the body is extended along the longitudinal direction, wherein the stopper has a polygonal cross section at the part connected to the body, and wherein two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper are larger than the radius of the circular cross section of the end of the body.
2. The medical thread of claim 1, wherein the two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper are 1.5 times or more of the radius of the circular cross section of the end of the body.
3. The medical thread of claim 1, wherein the stopper is placed perpendicularly to the longitudinal direction of the body adjacent thereto, and has a shape of polygonal prism or polygonal pyramid.
4. The medical thread of claim 1, wherein the stopper has a thickness of 0.1 mm to 5 mm.
5. The medical thread of claim 1, wherein a side of the polygonal cross section of the stopper at the part connected to the body has a length of 1 mm to 5 mm.
6. The medical thread of claim 1, wherein the edge of the stopper is formed in a tapered shape.
7. The medical thread of claim 1, wherein the attachment force between the body and the stopper (stopper attachment force) is 2 kgf or higher.
8. The medical thread of claim 1, wherein the penetration resistance of the stopper is 0.15 kgf or higher.
9. The medical thread of claim 1, wherein each of the body and the stopper independently comprises one or more polymers selected from polydioxanone (PDO), polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA), polytrimethylcarbonate (PTMC), polypropylene (PP), Nylon and polytetrafluoroethylene (PTFE), and copolymers thereof.
10. The medical thread of claim 1, wherein the medical thread has a surgical needle combined to the other end of the body which is not the end connected to the stopper.
11. The medical thread of claim 1, wherein the surface of the body comprises plural barbs protruding outward.
12. A method for manufacturing a medical thread, comprising the steps of: preparing a body extended along the longitudinal direction; heating and melting one end of the body; injecting the melted end of the body into a mold having a predetermined shape to form a stopper at the end of the body; cooling and separating the body and the stopper from the mold, wherein the end of the body connected to the stopper has a circular cross section, wherein the stopper has a polygonal cross section at the part connected to the body, and wherein two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper are larger than the radius of the circular cross section of the end of the body.
13. The method for manufacturing a medical thread of claim 12, further comprising step of adjusting the position of the stopper relative to the melted end of the body.
14. The method for manufacturing a medical thread of claim 12, wherein, in the step of cooling and separating the body and the stopper from the mold, the body and the stopper are cooled with a cooling air amount of 0.01 to 3 mpa for a time of 5 to 120 seconds.
15. The method for manufacturing a medical thread of claim 12, wherein, in the step of heating and melting one end of the body, the heating temperature is 50 to 400° C.
Description
BRIEF EXPLANATION OF THE DRAWINGS
[0023]
[0024]
[0025]
[0026]
CONCRETE MODE FOR CARRYING OUT THE INVENTION
[0027] The present invention is explained in detail below.
[0028] The medical thread of the present invention comprises a body; and a stopper connected to one end of the body, wherein the end of the body connected to the stopper has a circular cross section, wherein the body is extended along the longitudinal direction, wherein the stopper has a polygonal cross section at the part connected to the body, and wherein two or more—more concretely, three or more—of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper are larger than the radius of the circular cross section of the end of the body.
[0029] In an embodiment, the two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 1.5 times or more—more concretely, 2 times or more, 2.5 times or more, 3 times or more, 3.5 times or more, 4 times or more, 4.5 times or more, or 5 times or more—of the radius of the circular cross section of the end of the body. In addition, the two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 15 times or less—more concretely, 14.5 times or less, 14 times or less, 13.5 times or less, 13 times or less, 12.5 times or less, or 12 times or less—of the radius of the circular cross section of the end of the body.
[0030] More concretely, the two or more (preferably, three or more) of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 1.5 times to 15 times—still more concretely 2 times to 15 times, still more concretely 5 times to 15 times, and still more concretely 5 times to 12 times—of the radius of the circular cross section of the end of the body.
[0031] In an embodiment, the stopper can be placed perpendicularly to the longitudinal direction of the body adjacent thereto, and have a shape of polygonal prism or polygonal pyramid.
[0032] In an embodiment, without limitation thereto, the polygon of the cross section of the stopper can be, for example, triangle as the simplest, square, pentagon or hexagon, or it may a polygon of various shape such as star shape, cross shape, or the like. In addition, the stopper can have a shape of polygonal prism or polygonal pyramid corresponding to such a polygonal cross section.
[0033] In an embodiment, the stopper can have a thickness of 0.1 mm to 5 mm, and more concretely 0.1 mm to 3 mm or 0.1 mm to 1 mm. If the stopper is too thinner than the above, such stopper may not stop at the skin tissue and thus it may break away therefrom. If the stopper is too thicker than the above, such stopper may cause pain due to feeling of foreign body.
[0034] In an embodiment, a side of the polygonal cross section of the stopper at the part connected to the body can have a length of 1 mm to 5 mm, more concretely 1 mm to 4 mm or 2 mm to 4 mm, and still more concretely 1 mm to 3 mm or 2 mm to 3 mm.
[0035] In an embodiment, the attachment force between the body and the stopper (stopper attachment force) can be 2 kgf or higher, and more concretely 2.1 kgf or higher, 2.2 kgf or higher, 2.3 kgf or higher, 2.4 kgf or higher, or 2.5 kgf or higher. There is no special limitation to the upper limit of the stopper attachment force, and it can be, for example, 10 kgf or lower, 9 kgf or lower, 8 kgf or lower, or 7 kgf or lower, but it is not limited thereto.
[0036] In an embodiment, the penetration resistance of the stopper can be 0.15 kgf or higher, and more concretely 0.16 kgf or higher, 0.17 kgf or higher, 0.18 kgf or higher, 0.19 kgf or higher, or 0.2 kgf or higher. There is no special limitation to the upper limit of the penetration resistance of the stopper, and it can be, for example, 1 kgf or lower, 0.9 kgf or lower, 0.8 kgf or lower, 0.7 kgf or lower, 0.6 kgf or lower, or 0.5 kgf or lower, but it is not limited thereto.
[0037] In an embodiment, in case of using a yarn of 30 Size standard according to Pharmacopedia of the United States of America (USP) as the body of the medical thread, the stopper attachment force can be 2.5 kgf or higher and the penetration resistance can be 0.2 kgf or higher—which are the better properties as compared with a thread having a yarn of the same standard and a circular stopper of the same surface area of cross section.
[0038] In an embodiment, in case of using a yarn of 00 Size standard according to USP as the body of the medical thread, the stopper attachment force can be 4.5 kgf or higher and the penetration resistance can be 0.4 kgf or higher—which are the better properties as compared with a thread having a yarn of the same standard and a circular stopper of the same surface area of cross section.
[0039] In an embodiment, in case of using a yarn of 01 Size standard according to USP as the body of the medical thread, the stopper attachment force can be 5.2 kgf or higher and the penetration resistance can be 0.3 kgf or higher—which are the better properties as compared with a thread having a yarn of the same standard and a circular stopper of the same surface area of cross section.
[0040] In an embodiment, in case of using a yarn of 02 Size standard according to USP as the body of the medical thread, the stopper attachment force can be 5.2 kgf or higher and the penetration resistance can be 0.3 kgf or higher—which are the better properties as compared with a thread having a yarn of the same standard and a circular stopper of the same surface area of cross section.
[0041] In an embodiment, the body and the stopper can be formed from the same material or from different materials, and each of them independently can comprise one or more polymers selected from polydioxanone (PDO), polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA), polytrimethylcarbonate (PTMC), polypropylene (PP), Nylon and polytetrafluoroethylene (PTFE), and copolymers thereof. Herein, polydioxanone (PDO), polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA) and polytrimethylcarbonate (PTMC) are bio-absorbable polymer materials, and polypropylene (PP), Nylon and polytetrafluoroethylene (PTFE) are non-absorbable polymer materials.
[0042] In an embodiment, the body and the stopper can be formed from the same material. For example, after forming the body first, the stopper can be formed from the same material by melting the material of the body.
[0043] In an embodiment, the medical thread can have a surgical needle combined to the other end of the body which is not the end connected to the stopper.
[0044] Any kind of surgical needle can be used without limitation to its type as long as it can be inserted into the skin tissue and can penetrate the skin tissue.
[0045] In an embodiment, when the surgical needle is combined to the other end of the body which is not the end connected to the stopper of the medical thread, the two or more (preferably, three or more) of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 1.5 times or more—more concretely 2 times or more, still more concretely 2.5 times or more—of the radius of the outer diameter of the surgical needle (i.e., the circular cross section of the needle). In addition, the two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 7 times or less—more concretely 6 times or less, still more concretely 5 times or less—of the radius of the outer diameter of the surgical needle.
[0046] More concretely, the two or more (preferably, three or more) of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper can be 1.5 times to 7 times—still more concretely 2 times to 6 times, and still more concretely 2.5 times to 5.5 times—of the radius of the outer diameter of the surgical needle.
[0047] In an embodiment, the surface of the body can comprise plural barbs protruding outward (or projecting from the body).
[0048] The body can be formed in a thin and long shape extended along the longitudinal direction, and can have flexible property so that it may be deformed by external force. Herein, the longitudinal direction can be understood as a direction of extending of the center axis of the body.
[0049] In the outer side of the body, plural barbs tangentially (or obliquely) inclined in the longitudinal direction can be provided, and the plural barbs can be formed on the surface of the body with a predetermined angle to the longitudinal direction of the body. For example, the plural barbs can be angulated to the longitudinal direction of the body at 10° to 45° angles. By forming the plural barbs having a predetermined angle on the surface of the body as such, the plural barbs can be easily entangled to the skin tissue. The plural barbs herein can be formed along one direction (unidirectional type). Thus, according to an embodiment, the medical thread of the present invention can be a unidirectional type barbed thread.
[0050] Concretely, a first barb can be formed on the surface of one side of the body, and a second barb and a third barb can be formed on the surface of the other side of the body, spaced in circumferential direction from the first barb. And, the first barb, the second barb and the third barb can be formed in plurality, and each of them can be aligned (or arranged) in a row along the longitudinal direction of the body. Also, the first barb, the second barb and the third barb can be formed to have different angles relative to one other.
[0051] The medical thread according to the present invention can be a thread for use in suturing the part of the tissue wounded owing to surgical intervention or external injury, or a thread inserted into skin tissue and used for skin tightening.
[0052] In an embodiment, the edge of the stopper can be formed in a tapered shape, and in this case, the pressure applied to skin tissue by the edge of the stopper can be dispersed, consequently resulting in reduction of pain for the patient.
[0053] Also, the stopper can be placed perpendicularly to the longitudinal direction of the body. That is, the cross section of the stopper can be perpendicular to the body, and thus the medical thread can be easily entangled to the skin tissue.
[0054] Also, the center of the stopper can meet the longitudinal center of the body. In this case, the body can be placed at the center of the stopper, and thus the medical thread can be entangled to the skin tissue in balance.
[0055] Also, the above-explained barbs formed on the body in a unilateral direction can resist the one-directional movement of the medical thread, and in addition, the stopper provided at the end of the body can resist the counter-directional movement of the medical thread. That is, the medical thread can be fixed in the tissue of the subject by the barbs and the stopper.
[0056] Another aspect of the present invention provides a method for manufacturing a medical thread, comprising the steps of: preparing a body extended along the longitudinal direction; heating and melting one end of the body; injecting the melted end of the body into a mold having a predetermined shape to form a stopper at the end of the body; cooling and separating the body and the stopper from the mold, wherein the end of the body connected to the stopper has a circular cross section, wherein the stopper has a polygonal cross section at the part connected to the body, and wherein two or more of the distances from the center of gravity of the polygonal cross section of the stopper to each vertex of the stopper are larger than the radius of the circular cross section of the end of the body.
[0057] According to an embodiment, the body is prepared first, and one end of the body is heated and melted. Concretely, to melt the end of the body, the body is placed in a transfer unit that can transfer the body, and the body is injected into a pre-heated mold so that the end of the body can be heated and melted.
[0058] According to an embodiment, the step of preparing the body can further comprise a step of forming plural barbs on the surface of the body.
[0059] In an embodiment, the rate for injecting the body into the mold by the transfer unit can be 0.1 to 2 mm/s. Herein, if the injection rate is less than 0.1 mm/s, the productivity can decline, and if it is greater than 2 mm/s, the injection of the body might be performed faster than its melting and thereby the body might bend or injection itself might fail. Preferably, the rate for injecting the body into the mold by the transfer unit can be 0.1 to 1 mm/s, or 0.1 to 0.7 mm/s.
[0060] In an embodiment, the suitable injection rates according to the raw material and size of the body were confirmed, and the relationship therebetween is represented in the following Table 1. As shown in
TABLE-US-00001 TABLE 1 Diameter of the body Material (USP Size Injection rate (mm/s) of the body or EP Size) 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 PDO 02 Conform Conform Conform Conform Conform Conform Conform Non- Conform 01 Conform Conform Conform Conform Conform Conform Conform Non- Conform 00 Conform Conform Conform Conform Conform Conform Conform Non- Conform 20 Conform Conform Conform Conform Conform Conform Conform Non- Conform 30 Conform Conform Conform Conform Conform Conform Conform Non- Conform PGCL 01 Conform Conform Conform Conform Non- Non- Non- Non- Conform Conform Conform Conform 00 Conform Conform Conform Conform Non- Non- Non- Non- Conform Conform Conform Conform 20 Conform Conform Conform Conform Non- Non- Non- Non- Conform Conform Conform Conform 30 Conform Conform Conform Conform Non- Non- Non- Non- Conform Conform Conform Conform
[0061] According to an embodiment of the present invention, the mold can be heated by a heating unit, and the heating temperature can be 50 to 400° C. If the heating temperature is lower than 50° C., the body is not melted, and if it is higher than 400° C., excessive melting of the body in the mold may impede cooling, or lead to scorching and sticking of the body onto the mold. Preferably, the heating temperature can be 150 to 250° C.
[0062] Thereafter, the melted end of the body is injected into the mold having a predetermined shape so that the stopper can be formed at the end of the body.
[0063] In an embodiment, the mold having a predetermined shape can be of a shape of polygonal prism or polygonal pyramid as explained above.
[0064] Then, after the step of adjusting the position of the stopper relative to the end of the body, the stopper can be formed so that its center is positioned at the center of the body.
[0065] In an embodiment, the adjustment of the relative position between the stopper and the body can be carried out by adjusting the position of the transfer unit for the body or the position of the mold.
[0066] Then, after the step of cooling and separating the body and the stopper from the mold, the medical thread wherein the stopper is formed at one end of the body can be manufactured.
[0067] In an embodiment, in the cooling step, the cooling air amount can be 0.01 to 4.5 mpa, 0.01 to 4 mpa, 0.01 to 3.5 mpa, 0.01 to 3 mpa, 0.01 to 2 mpa, 0.01 to 1 mpa, 0.01 to 0.5 mpa, 0.01 to 0.3 mpa, or 0.01 to 0.2 mpa. If the cooling air amount is less than 0.01 mpa, the cooling may be insufficient and thereby the molded product might not be discharged, and if the cooling air amount is greater than 4.5 mpa, the cooling might become excessive, which might result in reduction of attachment force between the body and the stopper.
[0068] More concretely, the cooling air amount can be 0.01 mpa or more, 0.02 mpa or more, 0.03 mpa or more, 0.04 mpa or more, 0.05 mpa or more, 0.06 mpa or more, 0.07 mpa or more, 0.08 mpa or more, or 0.09 mpa or more, and 4.5 mpa or less, 4.0 mpa or less, 3.5 mpa or less, 3.0 mpa or less, 2.5 mpa or less, 2.0 mpa or less, 1.5 mpa or less, 1.0 mpa or less, 0.5 mpa or less, 0.4 mpa or less, 0.3 mpa or less, 0.2 mpa or less, or 0.1 mpa or less.
[0069] In an embodiment, in the cooling step, the cooling time can be 5 to 120 seconds, and more concretely, it can be 5 to 100 seconds, 5 to 80 seconds, 5 to 60 seconds, 5 to 50 seconds, 10 to 100 seconds, 15 to 80 seconds, 20 to 60 seconds, 25 to 50 seconds, 30 to 50 seconds, 25 to 45 seconds, 30 to 45 seconds, or 35 to 45 seconds. If the cooling time is less than 5 seconds, inappropriate shape may be formed, and if it is greater than 120 seconds, the production speed may decrease. According to an embodiment of the present invention, the cooling air amount can be 0.1 mpa or less, and the cooling time can be 35 to 45 seconds.
[0070] Meanwhile, the rate for injecting the body into the mold to form the stopper can vary depending on the size of the mold and the material of the body.
[0071] In an embodiment, the appearance and attachment force of the stopper depending on the cooling time were measured during manufacturing of the stopper under the fixed conditions of: 0.8 mm/s for PDO and 0.6 mm/s for PGCL with the injection rate of the body varying according to the size; 0.5 mpa as the cooling air amount; and 5 seconds as the waiting time after completion of the injection. The results are represented in the following Table 2. The stopper attachment force was evaluated as Excellent/Non-Conform according to the criteria shown in the following Table 3. That is, if the measured stopper attachment force was higher than the permit criteria of Table 3, it was determined as “Excellent,” and if the measured value was lower than the criteria, it was determined as “Non-Conform.” The diameter of the body means the diameter of the yarn which was not barbed.
TABLE-US-00002 TABLE 2 Diameter of the body Material (USP Size or Cooling time (s) of the body EP Size) 5 15 20 PDO 02 Non-Conform Excellent Excellent 01 Non-Conform Excellent Excellent 00 Non-Conform Excellent Excellent 20 Non-Conform Excellent Excellent 30 Non-Conform Excellent Excellent Diameter of the body Material (USP Size or Cooling time (s) of the body EP Size) 30 35 40 PGCL 01 Excellent Excellent Excellent 00 Excellent Excellent Excellent 20 Excellent Excellent Excellent 30 Excellent Excellent Excellent
TABLE-US-00003 TABLE 3 Acceptance criteria Size Average stopper attachment force (kgf) 02 1.80 01 1.80 00 1.50 20 1.10 30 0.68
[0072] The present invention is explained in more detail through the following Examples and Comparative Examples. However, the scope of the present invention is not limited to the Examples.
EXAMPLES
[0073] The yarns used in Examples and Comparative Examples below are represented in the following Table 4.
TABLE-US-00004 TABLE 4 USP Size Initial Material or EP Size strength Example 1/Comparative Example 1 PDO 02 Conform Example 2/Comparative Example 2 PDO 00 Conform Example 3/Comparative Example 3 PDO 30 Conform Example 4/Comparative Example 4 PGCL 01 Conform Example 5/Comparative Example 5 PGCL 30 Conform
[0074] Sample Preparation
[0075] The end of the yarn represented in the above Table 4 as the body of the medical thread was heated to prepare the medical thread of Example having a stopper with equilateral triangular cross section (cooling air amount condition: 0.5 mpa).
[0076] The length of one side of the equilateral triangular cross section of the stopper in Examples 1, 2 and 4 was 3 mm, and the length of one side of the equilateral triangular cross section of the stopper in Examples 3 and 5 was 2 mm.
[0077] Also, the end of the yarn represented in the above Table 4 was heated to prepare the medical thread of Comparative Example having a stopper with circular cross section of substantially the same area as the stopper of Example (cooling air amount condition: 0.5 mpa).
[0078] The diameter of the circular cross section of the stopper of Comparative Examples 1, 2 and 4 was 2.38 mm, and the diameter of the circular cross section of the stopper of Comparative Examples 3 and 5 was 1.62 mm.
[0079] In Example 1, the distances from the center of gravity of the equilateral triangle, which was the cross section of the stopper, to each vertex were 5.7 times to 7 times of the radius of the circular cross section of the end of the body connected to the stopper.
[0080] In Example 2, the distances from the center of gravity of the equilateral triangle, which was the cross section of the stopper, to each vertex were 8.6 times to 9.9 times of the radius of the circular cross section of the end of the body connected to the stopper.
[0081] In Example 3, the distances from the center of gravity of the equilateral triangle, which was the cross section of the stopper, to each vertex were 9.2 times to 11.6 times of the radius of the circular cross section of the end of the body connected to the stopper.
[0082] In Example 4, the distances from the center of gravity of the equilateral triangle, which was the cross section of the stopper, to each vertex were 8.6 times to 7 times of the radius of the circular cross section of the end of the body connected to the stopper.
[0083] In Example 5, the distances from the center of gravity of the equilateral triangle, which was the cross section of the stopper, to each vertex were 9.2 times to 11.6 times of the radius of the circular cross section of the end of the body connected to the stopper.
[0084] Test Item and Method
[0085] For each medical thread of Examples and Comparative Examples, the stopper attachment force and penetration resistance were measured according to the following methods.
[0086] (1) Stopper Attachment Force
[0087] Test for measuring the force required for the stopper breaking from the body of the medical thread [0088] 1) Device Condition for Measurement [0089] Load cell: 50 kgf [0090] Extension range: 200 mm [0091] Speed: 300 mm/min [0092] Length: 130 mm [0093] Number of tests: 6 for each sample [0094] 2) Test Method
[0095] A sample for test was prepared, a needle was passed through the rubber for measuring Tissue Drag, the needle was pulled slowly to fix the stopper to the rubber (
[0096] (2) Penetration Resistance
[0097] Test for measuring the strength applied to the stopper during its penetration through skin after fixation to skin pad [0098] 1) Device Condition for Measurement [0099] Load cell: 50 kgf [0100] Extension range: 200 mm [0101] Speed: 300 mm/min [0102] Length: 130 mm [0103] Number of tests: 5 for each sample [0104] 2) Test Method
[0105] A sample for test was prepared, the stopper was fixed to skin pad (
[0106] Test Results [0107] 1) Stopper Attachment Force (Maximum Load)
TABLE-US-00005 Stopper Tensile strain at attachment No. maximum load (%) force (kgf) Example 1 1 29.50 5.13 2 30.70 5.31 3 29.70 5.24 4 30.00 5.55 5 29.37 5.08 6 29.33 5.20 Average 29.77 5.25 Standard deviation 0.52 0.17 Comparative 1 28.17 4.81 Example 1 2 25.57 4.30 3 30.13 5.43 4 24.20 4.01 5 25.93 4.38 6 26.83 4.76 Average 26.81 4.62 Standard deviation 2.10 0.50 Example 2 1 42.30 4.69 2 42.53 4.71 3 41.73 4.57 4 40.53 4.35 5 40.63 4.40 6 39.83 4.42 Average 41.26 4.53 Standard deviation 1.08 0.16 Comparative 1 34.67 3.76 Example 2 2 35.37 4.01 3 40.27 4.40 4 36.67 3.93 5 38.30 4.17 6 36.50 3.78 Average 36.96 4.01 Standard deviation 2.04 0.24 Example 3 1 51.83 2.67 2 53.37 2.74 3 45.77 2.32 4 55.97 2.87 5 47.00 2.41 6 46.73 2.36 Average 50.11 2.56 Standard deviation 4.19 0.23 Comparative 1 35.97 1.80 Example 3 2 37.97 1.84 3 37.00 1.82 4 37.07 1.80 5 34.17 1.69 6 37.87 1.80 Average 36.67 1.79 Standard deviation 1.42 0.05 Example 4 1 36.17 5.33 2 38.40 5.49 3 37.07 5.23 4 39.10 5.36 5 37.03 5.10 6 40.47 6.02 Average 38.04 5.42 Standard deviation 1.59 0.32 Comparative 1 38.13 5.49 Example 4 2 35.57 5.02 3 34.97 4.88 4 36.57 5.19 5 36.30 5.12 6 35.93 5.19 Average 36.24 5.15 Standard deviation 1.08 0.20 Example 5 1 42.40 2.84 2 43.90 2.94 3 44.67 3.09 4 41.07 2.62 5 40.23 2.41 6 47.20 3.19 Average 43.24 2.85 Standard deviation 2.55 0.29 Comparative 1 41.47 2.63 Example 5 2 40.20 2.35 3 39.80 2.52 4 43.03 2.68 5 40.90 2.57 6 42.17 2.60 Average 41.26 2.56 Standard deviation 1.22 0.12
[0108] 2) Penetration Resistance (Maximum Load)
TABLE-US-00006 Tensile strain at Penetration No. maximum Load (%) resistance (kgf) Example 1 1 24.00 0.47 2 22.63 0.50 3 25.23 0.42 4 22.13 0.42 5 20.83 0.35 Average 22.97 0.43 Standard deviation 1.70 0.06 Comparative 1 20.70 0.22 Example 1 2 19.63 0.17 3 21.47 0.24 4 18.63 0.20 5 21.17 0.25 Average 20.32 0.22 Standard deviation 1.17 0.03 Example 2 1 26.07 0.45 2 25.17 0.46 3 26.63 0.41 4 25.87 0.42 5 25.00 0.40 Average 25.75 0.43 Standard deviation 0.67 0.03 Comparative 1 23.03 0.34 Example 2 2 23.73 0.40 3 22.63 0.32 4 23.33 0.31 5 21.17 0.34 Average 22.78 0.34 Standard deviation 0.99 0.03 Example 3 1 23.63 0.21 2 25.20 0.25 3 22.50 0.20 4 23.70 0.22 5 23.83 0.22 Average 23.77 0.22 Standard deviation 0.96 0.02 Comparative 1 22.27 0.15 Example 3 2 22.43 0.16 3 19.67 0.13 4 22.47 0.17 5 18.50 0.13 Average 21.07 0.15 Standard deviation 1.86 0.02 Example 4 1 25.83 0.46 2 24.93 0.37 3 24.53 0.42 4 24.60 0.44 5 25.83 0.38 Average 25.15 0.42 Standard deviation 0.64 0.04 Comparative 1 19.97 0.20 Example 4 2 21.50 0.20 3 20.30 0.25 4 20.40 0.21 5 20.80 0.14 Average 20.59 0.20 Standard deviation 0.59 0.04 Example 5 1 27.67 0.20 2 28.70 0.26 3 28.63 0.22 4 25.23 0.17 5 26.37 0.22 Average 27.32 0.21 Standard deviation 1.50 0.03 Comparative 1 24.93 0.14 Example 5 2 22.67 0.13 3 23.30 0.11 4 25.43 0.14 5 23.27 0.13 Average 23.92 0.13 Standard deviation 1.19 0.01
[0109] As can be seen from the above test results, the medical thread according to the present invention exhibits remarkably excellent stopper attachment force and penetration resistance as compared with a thread having a circular stopper of the same area of cross section, and thus by using it, the end can be fixed more firmly to the skin tissue.